RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
@zoeharcombe This large case series didn't appear to find obesity to confer additional risk of in-hospital mortality. (Caveat: I'm struggling to access the full text): https://t.co/Dd5qSY79sL https://t.co/HCKbHWpzHs
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @JohnNosta: KEY! Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. An interesting (cautious) look at ACE/ARBs and stati…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/HQOYHLohN0
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MiddeldorpS: Belangrijk voor patiënten die ACE remmers e.d. gebruiken. Het advies om gewoon door te gaan met deze medicijnen in tijden…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Muchísimas gracias
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
@Miguel_A_Maria Ahí va 👍🏼 https://t.co/kpG6Jf3rFt
RT @jesusanampa: Risk factors for in-hospital death in #COVID19 (Odds ratio): 🔸<65 years (1.93) 🔸CAD (2.70) 🔸Heart failure ( 2.48) 🔸Arrhyth…
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
KEY! Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. An interesting (cautious) look at ACE/ARBs and statins--better survival!? https://t.co/tTjxxVWM3z #COVID19 #coronavirus https://t.co/1V1u5TPOD9
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @drpatfarrell: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/KimZ81lTq5
Important: 4 articles ds le NEJM sur les IECA et ARA . Pas d'effets négatifs sur l'infection au COVID19. Rassurant pour les patients qui en prennent.
Badanie Czynniki ryzyka śmierci (pacjenci covid-19 w szpitalach): - >65 lat : 10% vs. 4,9% - choroba wieńcowa : 10,2% vs. 5,2% - arytmia serca : 11,5% v. 5,6% - palący : 9,4% v. 5,6% Zażywanie leków ACE inhibitors or ARBs - brak zwiększonej śmiertelnoś
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
https://t.co/yRPPmenkEu Thanks @NEJM and authors of the study. Now the picture is clearer: Risk of death in COVID19 is 79% higher in current smokers compared with non-smokers. 8910 patients, 169 hospitals, 3 continents... more solid than other small serie
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Belangrijk voor patiënten die ACE remmers e.d. gebruiken. Het advies om gewoon door te gaan met deze medicijnen in tijden van #COVID19 was de juiste. Er is geen averechts effect dus!
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Sharing some important emerging science to ease ACE inhibitor hysteria! #COVID19
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @jesusanampa: Risk factors for in-hospital death in #COVID19 (Odds ratio): 🔸<65 years (1.93) 🔸CAD (2.70) 🔸Heart failure ( 2.48) 🔸Arrhyth…
Risk factors for in-hospital death in #COVID19 (Odds ratio): 🔸<65 years (1.93) 🔸CAD (2.70) 🔸Heart failure ( 2.48) 🔸Arrhythmia (1.95) 🔸COPD (2.96) 🔸Smoking (1.79) 🔥ACEi or ARB did not increase risk of in-hospital death @OncoAlert https://t.co/ssKvxnCfX
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MinnowWalsh: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/kDyYIDjlsM Important findings by @MRMe…
Factores asociados a peor pronóstico en 8910 pt. con #COVID__19, donde 515 murieron. No significancia en peores desenlaces en usar IECA o ARA2. https://t.co/Yqn0vDrbCy https://t.co/DTSCCLxVPY
@hawkdawk some interesting info
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
Dos publicaciones de @NEJM que confirman que las medicaciones para el tratamiento de la hipertensión no aumentan el riesgo de complicaciones del #coronavirus https://t.co/T2fntv1Vmp https://t.co/UaTHW84fSC
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Interesting article on factors a/w #COVID19 mortality. Receipt of ACEi, ARB, or statins not harmful. Maybe beneficial. RCTs should help with this...
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @CharlieTomson: Three papers confirming what @RenalAssoc @escardio and others said all along: RAS inhibitors do not make people more lik…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MinnowWalsh: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/kDyYIDjlsM Important findings by @MRMe…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Bigger data just published. Similar result. https://t.co/X72gsSvLa8
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @drpatfarrell: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/KimZ81lTq5
RT @ethanjweiss: Maybe don't stop the statin? https://t.co/Gnp9WieRc1 https://t.co/iqX9ZGiGSJ
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…